Author, Renowned Innovator, and Accomplished Executive London, UK, Jan. 14, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Bubblr Inc., (OTC PINK: BBLR), ("Bubblr" or the "Company"), an ethical technology company focused on the development and commercialization of mobile-first technologies, today announced that the Board of Directors has appointed Otto Berkes… Read More..

- Phase 3 REGAL Study of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML) Patients Underway in United States and Europe - - License Agreement with 3D Medicines for Development and Commercialization of GPS in China Initiates Commercialization Strategy for GPS - - Balance Sheet Significantly Strengthened in 2020 with Preliminary… Read More..

NEW YORK, Jan. 13, 2021 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced the Pre-IND meeting requested on 22 December 2020 for HT-001 with the U.S. Food and Drug Administration (FDA) Division of Dermatology and Dental Products has been granted to receive written responses only from… Read More..